Temporal trends in obesity, osteoporosis treatment, bone mineral density, and fracture rates: A population-based historical cohort study

Journal of Bone and Mineral Research

Volumn 29, Issue 4, 2014, Pages 952-959

  Leslie, William D ^a   Lix, Lisa M ^b   Yogendran, Marina S ^b   Morin, Suzanne N ^c   Metge, Colleen J ^b   Majumdar, Sumit R ^d  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

BONE MINERAL DENSITY; DXA; EPIDEMIOLOGY; FRACTURES; OSTEOPOROSIS

Indexed keywords

ADULT; AGED; ARTICLE; BONE DENSITOMETRY; BONE DENSITY; CANADA; DISEASE ASSOCIATION; FEMALE; FEMUR NECK; FRAGILITY FRACTURE; HUMAN; LUMBAR SPINE; MIDDLE AGED; OBESITY; POPULATION RESEARCH; TREND STUDY; COHORT ANALYSIS; COMPLICATION; EPIDEMIOLOGY; FRACTURE; HEALTH SURVEY; OSTEOPOROSIS; PATHOPHYSIOLOGY;

BONE DENSITY; COHORT STUDIES; FEMALE; FRACTURES, BONE; HUMANS; MANITOBA; MIDDLE AGED; OBESITY; OSTEOPOROSIS; POPULATION SURVEILLANCE;

EID: 84897870429     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2099     Document Type: Article

References (39)

1. Jaglal SB, Sherry PG, Schatzker J., The impact and consequences of hip fracture in Ontario. Can J Surg. 1996; 39: 105-11.
2. Melton LJ III, Epidemiology worldwide. Endocrinol Metab Clin North Am. 2003; 32: 1-13 v.
3. Johnell O, Kanis JA., An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006; 17: 1726-33.
4. Ioannidis G, Papaioannou A, Hopman WM, et al. Relation between fractures,mortality: results from the Canadian Multicentre Osteoporosis Study. CMAJ. 2009; 181: 265-71.
5. Kanis JA, Oden A, McCloskey EV, Johansson H, Wahl DA, Cooper C., A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int. 2012; 23: 2239-56.
6. Cooper C, Cole ZA, Holroyd CR, et al. Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos Int. 2011; 22: 1277-88.
7. Jaglal SB, Weller I, Mamdani M, et al. Population trends in BMD testing, treatment, and hip and wrist fracture rates: are the hip fracture projections wrong ? J Bone Miner Res. 2005; 20: 898-05.
8. Abrahamsen B, Vestergaard P., Declining incidence of hip fractures and the extent of use of anti-osteoporotic therapy in Denmark 1997-2006. Osteoporos Int. 2010; 21: 373-80.
9. Hiligsmann M, Bruyere O, Roberfroid D, et al. Trends in hip fracture incidence and in the prescription of antiosteoporosis medications during the same time period in Belgium (2000-2007). Arthritis Care Res (Hoboken). 2012; 64: 744-50.
10. Murad MH, Drake MT, Mullan RJ, et al. Clinical review. Comparative effectiveness of drug treatments to prevent fragility fractures: a systematic review and network meta-analysis. J Clin Endocrinol Metab. 2012; 97: 1871-80.
11. De Laet C, Kanis JA, Oden A, et al. Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int. 2005; 16: 1330-8.
12. Melton LJ III, Kanis JA, Johnell O. Potential impact of osteoporosis treatment on hip fracture trends. J Bone Miner Res. 2005; 20: 895-7.
13. Looker AC, Flegal KM., Melton LJ III. Impact of increased overweight on the projected prevalence of osteoporosis in older women. Osteoporos Int. 2007; 18: 307-13.
14. Kanis JA, McCloskey EV, Johansson H, Oden A, Melton LJ III, Khaltaev N., A reference standard for the description of osteoporosis. Bone. 2008; 42: 467-75.
15. Looker AC, Wahner HW, Dunn WL, et al. Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int. 1998; 8: 468-89.
16. Looker AC, Melton LJ III, Borrud LG, Shepherd JA., Changes in femur neck bone density in US adults between 1988-1994 and 2005-2008: demographic patterns and possible determinants. Osteoporos Int. 2012; 23: 771-80.
17. Kanis JA, Oden A, Johansson H, Borgstrom F, Strom O, McCloskey E., FRAX and its applications to clinical practice. Bone. 2009; 44: 734-43.
18. Brauer CA, Coca-Perraillon M, Cutler DM, Rosen AB., Incidence and mortality of hip fractures in the United States. JAMA. 2009; 302: 1573-9.
19. Leslie WD, O'Donnell S, Jean S, et al. Trends in hip fracture rates in Canada. JAMA. 2009; 302: 883-9.
20. Leslie WD, Sadatsafavi M, Lix LM, et al. Secular decreases in fracture rates 1986-2006 for Manitoba, Canada: a population-based analysis. Osteoporos Int. 2011; 22: 2137-43.
21. Roos NP, Shapiro E., Revisiting the Manitoba Centre for Health Policy and Evaluation and its population-based health information system. Med Care. 1999; 37: JS10-4.
22. Kozyrskyj AL, Mustard CA., Validation of an electronic, population-based prescription database. Ann Pharmacother. 1998; 32: 1152-7.
23. Leslie WD, Metge C., Establishing a regional bone density program: lessons from the Manitoba experience. J Clin Densitom. 2003; 6: 275-82.
24. Leslie WD, MacWilliam L, Lix L, Caetano P, Finlayson GS., A population-based study of osteoporosis testing and treatment following introduction of a new bone densitometry service. Osteoporos Int. 2005; 16: 773-82.
25. Leslie WD, Caetano PA, MacWilliam LR, Finlayson GS., Construction and validation of a population-based bone densitometry database. J Clin Densitom. 2005; 8: 25-30.
26. Leslie WD, Tsang JF, Caetano PA, Lix LM., Effectiveness of bone density measurement for predicting osteoporotic fractures in clinical practice. J Clin Endocrinol Metab. 2007; 92: 77-81.
27. Leslie WD., The importance of spectrum bias on bone density monitoring in clinical practice. Bone. 2006; 39: 361-8.
28. Lix LM, Azimaee M, Osman BA, et al. Osteoporosis-related fracture case definitions for population-based administrative data. BMC Public Health. 2012; 12: 301.
29. Fraser LA, Langsetmo L, Berger C, et al. Fracture prediction and calibration of a Canadian FRAX(R) tool: a population-based report from CaMos. Osteoporos Int. 2011; 22: 829-37.
30. Kanis JA, Johansson H, Oden A, et al. A meta-analysis of milk intake and fracture risk: low utility for case finding. Osteoporos Int. 2005; 16: 799-804.
31. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP., Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007; 335: 806-8.
32. Harrell FE., Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis. New York: Springer; 2001.
33. Fitzmaurice G, Laird N, Ware J., Applied longitudinal analysis. Hoboken, NJ: Wiley; 2004.
34. Cheung E, Bow C, Loong C, et al. A secular increase in BMD in Chinese women. J Bone Miner Metab. Epub 2013 Apr 30. DOI: 10.1007/s00774-013-0463-8
35. Ford ES, Mokdad AH., Epidemiology of obesity in the Western Hemisphere. J Clin Endocrinol Metab. 2008; 93: S1-8.
36. Wild S, Roglic G, Green A, Sicree R, King H., Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27: 1047-53.
37. Romero CX, Romero TE, Shlay JC, Ogden LG, Dabelea D., Changing trends in the prevalence and disparities of obesity and other cardiovascular disease risk factors in three racial/ethnic groups of USA adults. Adv Prev Med. 2012; 2012: 172423.
38. Curtis JR, Mudano AS, Solomon DH, Xi J, Melton ME, Saag KG., Identification and validation of vertebral compression fractures using administrative claims data. Med Care. 2009; 47: 69-72.
39. Robbins JM, Herman MA., Estimation of the causal effects of time-varying exposures. In:, Fitzmaurice G, Davidian M, Verbeke G, Molenberghs G, editors. Longitudinal data analysis. Boca Raton, FL: Chapman and Hall/CRC Press; 2008. p. 553-600.